Dermal and transdermal drug delivery systems: Current and future prospects

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 13, Issue 3, 2006, Pages 175-187

  Brown, Marc B ^a,b   Martin, Gary P ^a   Jones, Stuart A ^a   Akomeah, Franklin K ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MEDPHARM LTD   (United Kingdom)

Author keywords

Dermal; Drug Delivery; Permeability; Skin; Transdermal

Indexed keywords

CLONIDINE; DICLOFENAC; ESTRADIOL; FENTANYL; GLYCERYL TRINITRATE; LIDOCAINE; NICOTINE; OLIGONUCLEOTIDE; OXYBUTYNIN; PEPTIDE; PROTEIN; SCOPOLAMINE; TESTOSTERONE; TITRAGESIA;

ABRASION; ARTICLE; COST EFFECTIVENESS ANALYSIS; DEVICE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; ELECTROPORATION; HUMAN; IONTOPHORESIS; LIPOPHILICITY; LOW LEVEL LASER THERAPY; MOLECULAR WEIGHT; NONHUMAN; PAIN; PRIORITY JOURNAL; RADIOFREQUENCY; SAFETY; SKIN ABRASION; SKIN PERMEABILITY; SKIN PROTECTION; TRANSDERMAL PATCH; ULTRASOUND;

ADMINISTRATION, CUTANEOUS; DERMABRASION; DRUG DELIVERY SYSTEMS; ELECTROPORATION; FORECASTING; HUMANS; INJECTIONS, JET; IONTOPHORESIS; NEEDLES; PHONOPHORESIS; PUNCTURES; SKIN ABSORPTION;

EID: 33645286192     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540500455975     Document Type: Article

References (143)

1. Akomeah, F., Nazir, T., Martin, G. P., and Brown, M. B. 2004. Effect of heat on the percutaneous absorption and skin retention of 3 model penetrants. Eur. J. Pharm. Sci. 21:337-345.
2. Allen, M. G., Prausnitz, M. R., McAllister, D. V., and Cross, F. P. M. 2002. Microneedle devices and methods of manufacture and use thereof. Patent (Serial Number U.S. 6, 334,856).
3. Alza Website. 2005. Retrieved on 3 January 2005 from the World Wide Web: http://www.alza.com/
4. Archer, D. F., Cullins, V., Creasy, D. W., and Fisher, A. C. 2004. The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy. Contraception 69:189-195.
5. Ashburn, M. A., Ogden, L. L., Zhan, J., Love, G., and Bastsa, S. V. 2003. Pharmacokinetics of transdermal fentanyl delivered with and without controlled heat. J. Pain 4:291-297.
6. Babu, R. J., Kanikkannan, N., and Kikwai, L., et al. 2003. The influence of various methods of cold storage on the permeation of melatonin and nimesulide. J. Control. Rel 86:49-57.
7. Badkar, A. V., and Banga, A. K 2002. Electrically enhanced transdermal delivery of a macromolecule. J. Pharm. Pharmacol. 54:907-912.
8. Banga, A. K. 1998. Electrically Assisted Transdermal and Topical Drug Delivery. London: Taylor and Francis, pp. 13-28.
9. Banga, A. K., Bose, S., and Ghosh, T. K. 1999. Iontophoresis and electroporation: comparisons and contrasts. Int. J. Pharm. 179:1-19.
10. Baron, E. D., Harris, L., Redpath W. S., et al. 2003. Laser assisted penetration of topical anaesthesia. Arch. Dermatol. 139:1288-1290.
11. Barry, B. W. 2001. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci. 14:101-114.
12. Blank, I. H., Scheuplein, R. J., and Macfarlane, D. J. 1967. Mechanism of percutaneous absorption III. The effect of temperature on the transport of non-electrolytes across the skin. J. Invest. Dermatol. 49:582-589.
13. Bommannan, D. B., Tamada, J., Leung, L. and Potts, R. O. 1994. Effects of electroporation on transdermal iontophoretic delivery of luteinizing-hormone- releasing hormone (LHRH) in vitro. Pharm. Res. 11:1809-1814.
14. Bos, J. D., and Meinardi, M. M. 2000. The 500 Dalton rule for skin penetration of chemical compounds and drugs. Exp Dermatol. 9:165-169.
15. Boucaud, A., Garrigue, M. A., and Machet, L., et al. 2002. Effect of sonication parameters on transdermal delivery of insulin to hairless rats. J. Control. Rel. 81:113-119.
16. Burkoth, T. L., Bellhouse, B. J., and Hewson, G., et al. 1999 Transdermal and transmucosal powdered delivery. Crit. Rev Ther. Drug Carrier. Syst. 16:331-384.
17. Carmichael, A. J. 1994. Skin sensitivity and transdermal drug delivery. A review of the problem. Drug Saf. 10:151-159.
18. Cevc, G. 1996. Transferosomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration and transdermal drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 13:257-388.
19. Cevc, G. 2003. Transferosomes: innovative transdermal drug carriers. In Modified Release Drug Delivery Technology, eds., Rathbone, M. J., Hadgraft, J. and Roberts, M. S., 533-560. New York: Marcel Dekker.
20. Chang, S. L., Hofmann, G. A., and Zhang, L., et al. 2000. The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones. J. Control. Rel. 66:127-133.
21. Ciernik, I. F., and Krayenbuhl, B. H. 1996. Puncture mediated gene transfer into skin. Hum. Gene. Ther. 7:893-899.
22. clarys, P., Alewaeters, K., Jadoul, A., et al. 1998. In vitro percutaneous penetration through hairless rat skin: influence of temperature, vehicle and penetration enhancers. Eur. J. Pharm. Biopharm. 46:279-283.
23. Cleary G. W. 1991. Transdermal drug delivery. Cosmet Toil. 106:197.
24. Cleary, G. W. 1993. Transdermal delivery systems; a medical rationale. In Topical Drug Bioavailability Bioequivalence and Penetration, eds. Shah, V. P., and Maibach, H. I., 17-68. New York: Plenum Press.
25. Colin Long, C. 2002. Common skin disorders and their topical treatment, In Dermatological and Transdermal Formulations Walters KA., ed, New York: Marcel Dekker, pp 41-60.
26. Cormier, M., Trautman, J., and Kim, H. L., et al. 2001. Skin treatment apparatus for sustained transdermal drug delivery. Patent (serial number WO 01/41864 A1).
27. Cramer, M. P., and Saks, S. R. 1994. Translating safety, efficacy and compliance into economic value for controlled release dosage forms. Pharmacoeconomics 5:482-504.
28. Crocker, P., Maynard, K., and Little, M. 2001. Pain free blunt needle injection technology. Innov. Pharmaceut. technol. 9:111-115.
29. Denet, A. R., Vanbever, R., and Préat, V. 2004. Skin electroporation for topical and transdermal delivery. Adv. Drug. Del. Rev. 56:659-674.
30. Doukas, A. G., and Kollias, N. 2004. Transdermal delivery with a pressure wave. Adv. Drug. Del. Rev. 56:559-579.
31. Down, J., Harvey, N. G., and Martin, F. E., et al. 2001. Skin permeability enhancing device to withdraw or administer a substance and method of manufacture. Patent (serial number WO 0193946).
32. Down, J., and Harvey, N. G. 2003. Minimally invasive systems for transdermal drug delivery. In Transdermal Drug Delivery, eds. Guy R. H. and Hadgraft, J., 327-360. New York Marcel Dekker.
33. Elias, P. M. 1983. Epidermal lipids, barrier function and desquamation. J. Invest. Dermatol. 80:44-19.
34. Elias, P. M., Feingold, K. R., and Tsai, J., et al. 2003. Metabolic approach to transdermal drug delivery. In Transdermal Drug Delivery, eds. Guy, R. H, and Hadgraft, J., 285-304. New York: Marcel Dekker.
35. Flynn, G., Yalkowsky, S. H., and Roseman, T. J. 1974. Mass transport phenomena and models. J. Pharm. Sci. 63:479-510.
36. Frei, A., Andersen, S., Hole, P., and Jensen, N. H. 2003. A one year health economic model comparing transdermal fentanyl with sustained-release morphine in the treatment of chronic non-cancer pain. J. Pain Palliat. Care. Pharmacother. 17:5-26.
37. Fugiwara, H., and Matsumoto, T. 1998. Sampling device of suction effusion fluid. Patent (serial number U.S. 5,782,871).
38. Genetronics Wesite. 2005. Retrieved on 31 January 2005 from the World Wide Web: http://www.genetronics.com/
39. Gerstel, M. S., and Place, V. A. 1976. Drug delivery device. Patent (serial number U.S. 3,964, 482).
40. Ghosh T. K., Pfister W. R., and Yum S. I. 1997. In Transdermal and topical Drug Delivery Systems. Illinois: Interpharm Press.
41. Godin B., and Touitou, E. 2003. Ethosomes: new prospects in transdermal delivery. Crit. Rev. Ther. Drug Carrier. 20:63-102.
42. Godshall, N. 1996. Micromechanical patch for enhancing delivery of compounds through the skin. Patent (serial number WO 9637256).
43. Godshall, N., and Anderson, R. 1999. Method and apparatus for disruption of the epidermis. Patent (serial number U.S. 5,879, 326).
44. Grosh, S. 2000. Transdermal drug delivery-opening doors for the future. Euro. Pharm. Contractor (November). 4:30-32.
45. Gupta, S. K., Southam, M., Sathyan, G., and Klausner, M. 1998. Effect of current density on pharmacokinetics following continuous or intermittent input from a fentanyl electrotransport system, J. Pharm. Sci. 87:976-981.
46. Gupta, S. K., Sathyan, G., and Phipps, B. 1999. Reproducible fentanyl doses delivered intermittently at different time intervals from an electrotransport system. J. Pharm. Sci. 88:835-841.
47. Guy, R. H., Kalia, Y. N., and Delgado-Charro, M. B. 2000. Iontophoresis: electrorepulsion and electroosmosis. J. Control. Rel. 64:129-132.
48. Hadgraft, J. 1996. Pharmaceutical aspects of transdermal nitroglycerin. Int. J. Pharm. 135:1-11.
49. Helmstädter, A. 2001. The history of electrically assisted transdermal drug delivery (iontophoresis). Pharmazie 56:583-587.
50. Henzel, M. R., and Loomba, P. K. 2003. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice. J. Reprod. Med. 48:525-540.
51. Hogan, D. J., and Maibach, H. I. 1990. Adverse dermatologic reactions to transdermal drug delivery systems. J. Am. Acad. Dermatol. 22:811-8144.
52. Hull, W. 2002. Heat-enhanced transdermal drug delivery: A survey paper. J. Appl. Res. Clin. Exp. Ther. 2. Retrieved on 20 February 2006 from the World Wide Web: www.jrnlappliedresearch.com/articles/Vol2Iss1/Hull.htm.
53. Jacques, S. L., McAuliffe, D. J., Blank, I. H., and Parrish, J. A. 1988. Controlled removal of human stratum corneum by pulsed laser to enhance percutaneous transport. Patent (serial number U.S. 4, 775, 361).
54. Jang, K. 1997. Skin perforating device for transdermal medication. Patent (serial number U.S. 5,611,806).
55. Jang, K. 1998. Skin perforating apparatus for transdermal medication. Patent (serial number U.S. 5,843,114).
56. Jarupanich, T., Lamlertkittikul, S., and Chandeying, V. 2003. Efficacy, safety and acceptability of a seven-day, transdermal estradiol patch for estrogen replacement therapy. J. Med. Assoc. Thai. 86:836-845.
57. Kalia, Y. N., Naik, A., Garrison, J., and Guy, R. H. 2004. Iontophoretic drug delivery. Adv. Drug Del. Rev. 56:619-658.
58. Kamen, D. 1998. System for delivery of drugs by transport, Patent (serial number WO 98/11937).
59. Kanikkannan, N. 2002. Iontophoresis based transdermal delivery systems. Biodrugs 16:339-347.
60. Kasting, G. B., and Bowman, L. A. 1990. Electrical analysis of fresh excised human skin: a comparison with frozen skin. Pharm. Res. 7:1141-1146.
61. Katz, N., Shapiro, D., Herrmann, T., Kellogg, S., Warner, N., Kost, J., and Custer, L. 2004. Ultrasound pretreatment of skin enhances the onset speed of EMLA cream. Anesth & Analg. 98:371-376.
62. Kaushik, S., Hord, A. H., Denson, D. D., McAllister, D. V., Smitra, S., Allen, M. G., and Prausnitz, M. R. 2001. Lack of pain associated with microfabricated microneedles. Anesth Analg. 92:502-504.
63. Klemsdal, T. O., Gjesdal, K., and Bredesen, J. E. 1992. Heating and cooling of the nitroglycerin patch application area modify the plasma level of nitroglycerin. Eur. J Clin. Pharmacol. 43:625-628.
64. Kormic, C. A., Santiago-Palma, J., Moryll, N., et al. 2003. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain. Drug Saf. 26:951-973.
65. Kuleza, J., and Dvoretzky, I. 2001 Multipurpose drug and heat therapy system. Patent (serial number WO 01/58408).
66. Larsen, R. H., Nielsen, F., Søresen, J. A., and Nielsen, J. B. 2003. Dermal penetration of fentanyl: Inter- and intraindividual variations. Pharmcol. Toxicol. 93:244-248.
67. Lee, S., McAuliffe, D. J., and Flotte, T. J., et al. 1998. Photomechanical transcutaneous delivery of macromolecules. J. Invest. Dermatol. 111:925-929.
68. Lee, S., Kollias, N., McAuliffe, D. J., et al. 1999. Topical drug delivery in humans with a single photomechanical wave. Pharm. Res. 16:514-518.
69. Lee, W. R., Shen, S. C., Lai, H. H., et al. 2001a. Transdermal drug delivery enhanced and controlled by erbium: YAG laser: A comparative study of lipophilic and hydrophilic drugs. J. Control. Rel. 75:155-166.
70. Lee, S., McAuliffe, D. J., Flotte, T. J., et al. 2001b. Permeabilization and recovery of the stratum corneum in vivo: the synergy of photomechanical waves and sodium lauryl sulphate. Lasers. Surg. Med. 29:145-150.
71. Lee, S., McAuliffe, D. J., Mulholland, S. E., and Doukas, A. G. 2001c. Photomechanbical transdermal delivery: the effect of laser confinement. Lasers Surg. Med. 28:344-347.
72. Lee, S., McAuliffe, D. J., Mulholland, S. E., and Doukas, A. G. 2001d. Photomechanical transdermal delivery of insulin in vivo. Lasers. Surg. Med. 28:282-285.
73. Lee, W. R., Shen, S. C., Wang, K. H., et al. 2003. Lasers and microdermabrasion enhance and control topical delivery of vitamin C. J. Invest. Dermatol. 121:1118-1125.
74. Lin, W. Q., Cormier, M., Samiee, A., et al. 2001a. Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux®) technology. Pharm. Res. 18:1789-1793.
75. Lin, W. Q., Theeuwes, F., and Cormier, M. 2001b. Device for enhancing transdermal flux of sampled agents. Patent (serial number WO 01/43643).
76. Longbridge, D. J., Sweeney, P. A., Burkoth, T. L., and Bellhouse, B. J. 1998. Effects of particle size and cylinder pressure on dermal powderject delivery of testosterone to conscious rabbits. Proc. Int. Symp. Control Rel Bioact. Mat. 25:964.
77. Marieb, E. N. 1997. Human Anatomy and Physiology. 4th ed. San Francisco: Benjamin Cummings, pp. 146.
78. Martanto, W., Davis, S. P., and Holiday, N. R. 2004. Transdermal delivery of insulin using microneedles in vivo. Pharm Res. 21:947-952.
79. Matriano, J. A., Cormier, M., and Johnson, J., et al. 2002 Macroflux technology: a new and efficient approach for intracutaneous immunization. Pharm. Res. 19:63-70.
80. Mezei, M., 1993. Liposomes and the skin. In Liposomes in drug delivery, eds. Gregoriadis, G., Florence, A. T., and Patel, H. New York: Harwood Academic, pp. 125-137.
81. Mikszta, J. A., Britingham, J. M., and Alarcon, J. 2001. Applicator having abraded surface coated with substance to be applied. Patent (serial number WO 01/89622 A1).
82. Mikszta, J. A., Alarcon, J., Britingham, J. M., et al. 2002. Improved genetic immunization via micromechanical disruption of skin barrier function and targeted epidermal delivery. Nat. Med. 8:415-419.
83. Mikszta, J. A., Britingham, J. M., and Alarcon, J., et al. 2003. Topical delivery of vaccines. Patent (serial number U.S. 6, 595, 947 B1).
84. Mitragotri, S., Blankschtein, D. and Langer, R. 1995. Ultrasound mediated transdermal protein delivery. Science. 269:850-853.
85. Mitragotri, S., Blankschtein, D., and Langer, R. 1996. Transdermal delivery using low frequency sonophoresis. Pharm. Res. 13:411-420.
86. Mitragotri, S. 2004. Low frequency sonophoresis. Adv. Drug. Del. Rev. 56:589-601.
87. Muddle, A. G., Longridge, D. J., and Sweeney, P. A., et al. 1997. Transdermal delivery of testosterone to conscious rabbits using powderject (R): A supersonic powder delivery system. Proc. Int Symp. Control. Rel. Bioact. Mat. 24:713.
88. Mulholland, S. E., Lee, S., McAuliffe, D. J. and Doukas A. G. 1999. Cell loading with laser generated stress waves: the role of stress gradient. Pharm Res. 16:514-518.
89. Murphy, M., and Carmichael, A. J. 2000. Transdermal drug delivery systems and skin sensitivity reactions, incidence and management. Am. J. Clin. Dermatol. 1:361-368.
90. Murthy, S. N. 1999 Magnetophoresis: an approach to enhance transdermal drug diffusion. Pharmazie 54:377-379.
91. Murthy, S. N., and Hiremath, R. R. 2001. Physical and chemical permeation enhancers in transdermal delivery of terbutaline sulphate. AAPS PharmSciTech. 2:1-5.
92. Neukermans, A. P., Poutiatine, A. I., and Sendelbeck, S., et al. 2001. Device and method for enhancing microprotrusion skin piercing. Patent (serial number WO 0141863).
93. Norwood Abbey Website. 2005. Retrieved on 31 January 2005 from the World Wide Web: http://www.norwoodabbey.com/indexresdev.htm
94. Ogiso, T., Hirota, T., Masahiro, I., et al. 1998. Effect of temperature on percutaneous absorption of terodiline and relationship between penetration and fluidity of stratum corneum lipids. Int. J. Pharm. 176:63-72.
95. Pachangula, R. 1997. Transdermal delivery of drugs. Ind. J. Pharm. 29:140-156.
96. Paranjape, M., Garra, J., and Brida, S., et al. 2003 A PDMS dermal patch for non-intrusive transdermal glucose sensing. Sens Actuators A 104:195-204.
97. Payne, R., Mathias, S. D., and Pasta, D. J., et al. 1998. Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine. J. Clin. Oncol. 16:1588-93.
98. Pellet, M., Raghavan, S. L., Hadgraft, J. and Davis, A. F. 2003. The application of supersaturated systems to percutaneous drag delivery. In: Transdermal Drug Delivery, eds. Guy, R. H., and Hadgraft, J., 305-326. New York: Marcel Dekker.
99. Pliquett, U., Vaughan, T. and Weaver, J. 1999. Apparatus and method for electroporation of tissue. Patent (serial number U.S. 5,983,131).
100. Prausnitz M. R. 2004. Microneedles for transdermal drug delivery. Adv. Drug Del. Rev. 56:581-587.
101. Sage, B. H., and Bock, C. R. 2001. Method and device for abrading the skin. Patent (serial number EP 1086719).
102. Saito, S., Kajiwara, Y. and Saito, A. 1999. Method and apparatus of sampling effusion fluid. Patent (serial number U.S. 5,882,317).
103. Schreier, H., and Bouwstra, J. 1994. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J. Control. Rel. 30:1-15.
104. Scheuplein, R. J., and Blank, I. H. 1971. Permeability of the skin. Physiol Rev. 51:702-747.
105. Shomaker, T. S., Zhang, J., Love. G., et al. 2000. Evaluating skin anaesthesia after administration of a local anaesthetic system consisting of an S-Caine™ patch and a controlled heat-aided drug delivery (CHADD™) patch in volunteers. Clin. J. Pain. 16:200-204.
106. Shomaker, T. S., Zhang, J., and Ashburn, M. A. 2001. A pilot study assessing the impact of heat on transdermal delivery of testosterone. J. Clin. Pharmacol. 41:677-682.
107. Singer, A. J., Homan, C. S., Church, A. L., and McClain, S. A. 1998. Low frequency sonophoresis: pathologic and thermal effects in dogs. Acad. Emerg. Med. 5:35-10.
108. Sintov, A., Krymbeck, I., and Daniel, D., et al. 2003. Radiofrequency microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. J. Control. Rel. 89:311-320.
109. Smith, N. B., Lee, S., Maione, E., et al. 2003. Ultrasound mediated transdermal transport of insulin in vitro through human skin using novel transducer designs. Ultrasound. Med. Biol. 29:311-317.
110. Southam, M., Bernstein, K. J., and Noorduin, H. 2001. Device for transdermal electrotransport of fentanyl and sufentanil. Patent (serial sumber U.S. 6,216,033).
111. Southwell, S., Barry, B. W., and Woodford, R. 1984. Variations in permeability of human skin within and between specimens. Int. J. Pharm. 18:299-309.
112. Stanley, T., Hull, W., and Rigby, L. 2001. Transdermal drug patch with attached pocket for controlled heating device. Patent (serial number U.S. 6,261, 595).
113. Steinsträsser, I., and Merkle, H. P. 1995. Dermal metabolism of topically applied drags: pathways and models reconsidered. Pharm. Acta Helv. 70:3-24.
114. Sugibayash, K., Kubo, H., and Mori, K. 2002. Device and electrode for electroporation. Patent (serial number WO 01/28624).
115. Svedman, P., Lunin, S. and Svedman, C. 1991. Administration of antidiuretic peptide (DDVAP) by way of suction de-epithelialised skin. Lancet. 337:1506-1509.
116. Svedman, P. 1995. Transdermal perfusion of fluids. Patent (serial number U.S. 5,441,490).
117. Svedman, P., Lundin, S., and Höglund, P., et al. 1996. Passive drug diffusion via standardized skin mini-erosion; methodological aspects and clinical findings with new device Pharm. Res. 13:1354-1359.
118. Svedman, P., and Svedman, C. 1998. Skin mini-erosion sampling technique; feasibility study with regard to serial glucose measurement. Pharm. Res. 15:883-888.
119. Tachibana, K. 1992. Transdermal delivery of insulin to alloxan-diabetic rabbits by ultrasound exposure. Pharm Res. 9:952-954.
120. Toole, J., Silagy, S., and Marie, A., et al. 2002 Evaluation of irritation and sensitisation of two 50 microg/day oestrogen patches. Maturitas 43:257-263.
121. TransPharma Medical Website 2005. Retrieved on 31 January 2005 from the World Wide Web: http://www.transpharmamedical.com/technology_rf.html
122. Trautman, J., Cormier, M. J., Kim, H. L., and Zuck, M. G. 2000. Device for enhancing transdermal agent flux. Patent (serial number U.S. 6,083,196).
123. Trautman, J., Wong, P. S., Daddona, P. E., et al. 2001 Device for enhancing transdermal agent flux. Patent (serial number U.S. 6,322,808 B1).
124. Treffel, P., Panisset, F., Humbert, P., et al. 1993. Effect of pressure on in vitro percutaneous absorption of caffeine. Acta. Derm. Venereol (Stockh). 73:200-202.
125. Tsai, J. C., Guy, R. H., Thornfeldt, C. R., et al. 1996. Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors. J. Pharm. Sci. 85:643-648.
126. Turner, N. G., Kalia, Y. N., and Guy, R. H. 1997. The effect of current on skin barrier function in vivo: recovery kinetics post iontophoresis. Pharm. Res. 14:1252-1255.
127. Tyle, P. 1986. Iontophoretic devices for drug delivery. Pharm. Res. 3:318-326.
128. Vanbever, R., Langers, G., Montmayeur, S., and Préat, V. 1998. Transdermal delivery of fentanyl: rapid onset of analgesia using skin electroporation. J. Control. Rel. 50:225-235.
129. Varvel, J. R., Shafer, S. L., and Hwang, S. S., et al. 1989. Absorption characteristics of transdermally administered fentanyl. Anaesthesiology 70:928.
130. Venkatraman, S., and Gale, R. 1998. Skin adhesives and skin adhesion 1. Transdermal drug delivery systems. Biomaterials, 19:1119-1136.
131. Vyteris Wesite. 2005. Retrieved on 31 January 2005 from the World Wide Web: http://www.vyteris.com/index.html
132. Wang, Y., Allen, L. V., Li, C., and Tu, Y. 1993. Iontophoresis of hydrocortisone across hairless mouse skin: investigation of skin alteration. J. Pharm. Sci. 82:1140-1144.
133. Wang, Y., Thakur, R., Fan, Q., and Michniak, B. 2005. Transdermal iontophoresis: Combination strategies to improve transdermal iontophoretic drug delivery. Eur. J. Pharm. Sci. 60:179-191.
134. Weaver, J. C., Vaughan, T. E., and Chizmadzhev, Y. A. 1999. Theory of electrical creation of aqueous pathways across skin transport barriers. Adv. Drug. Del. Rev. 35:21-39.
135. Whittington, R., and Faulds, D. 1994. Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency. Pharmacoeconomics 5:419-45. Review. Erratum in Pharmacoeconomics 1995 8:244.
136. Williams, A. C., and Barry, B. W. 2004. Penetration enhancers. Adv. Drug Del. Rev. 56:603-618.
137. Yang, S. I., Park, H. Y., Lee. S. H., et al. 2004. Transdermal eperisone elicits more potent and longer-lasting muscle relaxation than oral operisone. Pharmacology 71:150-156.
138. Yano, T., Nagakawa. A., Tsuji. M., and Noda. K. 1986. Skin permeability of various non-steroidal anti-inflammatory drugs in man. Life Sci. 39:1043-1050.
139. Yazdanian, M. 1994. Effect of freezing on cattle skin permeability. Int. J. Pharm. 103:93-96.
140. Yuzhakov, V. V., Sherman, F. F., Owens, G. D., and Gartstein, V. 2001. Apparatus and method for using an intracutaneous microneedle array. Patent (serial number U.S. 6,256,533).
141. Zars Website. 2005. Retrieved on 31 January 2005 from the World Wide Web: http://www.zars.com/
142. Zhang, L., Hofmann, G. A., and Rabussay, D. 2001. Electrically assisted transdermal method and apparatus for treatment of erectile dysfunction. Patent (serial number U.S. 6,266 560).
143. Zhang, L., Nolan, E., Kreitschitz, S., and Rabussay, D. P. 2002. Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation. Biochim. Biophys. Acta 1572:1-9.